This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Regulation (EU) 2024/568: Questions and answers clinic for the Veterinary Indust...
Galapagos is dropping its junior CD19 CAR-T as part of the Belgian biotech’s see...
Minutes - PDCO minutes of the 10-13 December 2024 meeting
Human medicines European public assessment report (EPAR): Locametz, gozetotide, ...
Biotech and drug stocks, collectively, are down an average of 16% over the past ...
Opinion/decision on a Paediatric investigation plan (PIP): Omvoh, Mirikizumab, d...
Opinion/decision on a Paediatric investigation plan (PIP): Uplizna, Inebilizumab...
A year and a half after Sanofi swooped in on Johnson & Johnson’s dismantled vacc...
Human medicines European public assessment report (EPAR): Xaluprine (previously ...
Human medicines European public assessment report (EPAR): Lydisilka, estetrol,dr...
If the FDA follows an advisory committee’s vote, it can potentially be a transfo...
The U.S. ranks 29th in life expectancy at birth among peer nations in the OECD. ...
Each year, flu experts from around the world gather to map out recommendations f...
Stunned by attacks on the scientific research system, early career scientists pl...
Implementation strategy of ICH Guideline M12 on drug interaction studies
ICH M12 on drug interaction studies - Scientific guideline